Related Experiment Video
Updated: Jan 1, 2026

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
Long-term transesophageal echocardiography follow-up after percutaneous left atrial appendage closure
Stephan Staubach1, Leonhard Schlatterbeck2, Moritz Mörtl1
1Klinik für Kardiologie, Pneumologie und Internistische Intensivmedizin, München Klinik Neuperlach, Munich, Germany.
Insights
Late peri-device leaks and device thrombi can occur after left atrial appendage occlusion (LAAO). These complications, though infrequent, warrant continued monitoring beyond the initial 12 months post-procedure.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Devices
Background:
- Percutaneous left atrial appendage occlusion (LAAO) is an alternative to anticoagulation for stroke risk reduction in atrial fibrillation.
- Device-related complications like peri-device leaks and thrombi are known risks, typically assessed up to 12 months post-procedure.
- Long-term data on these complications beyond one year are limited.
Purpose of the Study:
- To evaluate the incidence and characteristics of device-related complications after percutaneous left atrial appendage occlusion (LAAO) beyond the 12-month follow-up period.
- To assess the persistence and evolution of peri-device leaks and device thrombi over extended follow-up durations.
Main Methods:
- A prospective, 2-center, nonrandomized trial involving 63 patients who underwent successful LAAO at least 12 months prior.
- Structured transesophageal echocardiography (TEE) was performed for long-term assessment of peri-device leaks, device thrombi, and other device-related issues.
- Follow-up duration ranged from 1.0 to 7.5 years, with a median of 3.1 years post-implantation.
Main Results:
- The incidence of patients without detectable leaks increased significantly at long-term follow-up compared to 6-week assessments (P = .04).
- Major peri-device leaks (>5 mm) were observed in 3% of patients, and device thrombus was detected in 13%.
- Patients with device thrombus had larger 6-week peri-device leaks (median 3.0 mm vs 1.4 mm; P = .04). One of five ischemic stroke patients had a significant leak; no stroke patients had device thrombus.
Conclusions:
- Peri-device leaks and device thrombi remain potential complications during long-term follow-up after LAAO.
- The clinical significance of these late-occurring device-related complications necessitates further investigation in larger prospective studies.
Background:
Peri-device leaks and device thrombi are assumed to lead to ischemic events after percutaneous left atrial appendage occlusion (LAAO). While these device-related complications are well assessed until 12 months after LAAO, no data are available beyond this period.
Objective:
The purpose of this study was to assess device-related complications beyond 12 months after LAAO.
Methods:
All patients who underwent successful percutaneous LAAO ≥12 months ago in the 2 participating centers were screened for eligibility. After inclusion, structured transesophageal echocardiography (TEE) was performed to assess peri-device leaks, device thrombus, and other device-related complications.
Results:
A total of 63 patients were enrolled in the present prospective, 2-center, nonrandomized, single-arm trial. The median time from implantation until long-term TEE was 3.1 years (interquartile range 2.0-5.1 years), ranging from 1.0 to 7.5 years. The number of patients without a detectable leak increased significantly at long-term TEE compared with 6-week follow-up (P = .04). Major peri-device leaks (>5 mm) were detected in 2 patients (3%). Device thrombus was found in 8 patients (13%). Patients with device thrombus at long-term follow-up had larger peri-device leaks at 6-week follow-up than did those without thrombus formation (3.0 [interquartile range 2.7-3.5] vs 1.4 [interquartile range 0.0-2.6]; P = .04). Of those who suffered an ischemic stroke during long-term follow-up (n = 5), 1 patient showed a peri-device leak >5 mm. None of the patients with detected device thrombus had a stroke.
Conclusion:
Peri-device leaks and device thrombi continue to occur during long-term follow-up after LAAO. The clinical impact of these late occluder complications requires further evaluation in larger prospective trials.
Related Concept Videos
Endocarditis III: Medical Management
Cardiac Catheterization III: Left Heart Catheterization

